Claims for Patent: 6,559,322

Summary for Patent: 6,559,322

Title:	Process for preparation of a lactone from a cyclic ketone
Abstract:	The present invention provides a new biocatalyst whole cell system for converting cyclic ketones such as cyclopentanone/cyclohexanone to the corresponding lactones such as valerolactone/caprolactone. Another novel aspect of the present invention is that biocatalyst fungus Fusarium oxysporum f.sp. ciceri NCIM 1282 species has been found to be an efficient biocatalyst system for any biotransformation for the first time.
Inventor(s):	Mandal; Deendayal (Maharashtra, IN), Ahmad; Absar (Maharashtra, IN), Khan; Mohammed Islam (Maharashtra, IN), Kumar; Rajiv (Maharashtra, IN)
Assignee:	Council of Scientific and Industrial Research (New Delhi, IN)
Application Number:	10/032,203
Patent Claims:	1. A process for the preparation of a lactone from the corresponding cyclic ketone, comprising treating wet fungal mycelia with an alcoholic solution of a cyclic ketone substrate at a temperature in the range of 15 to 40.degree. C. for a period ranging between 2 to 200 hours and separating the biomass to obtain the lactone. 2. A process as claimed in claim 1 wherein the cyclic ketone used is selected from C5 to C6 ketones. 3. A process as claimed in claim 2 wherein the cyclic ketone used is selected from cyclopentanone and cyclohexanone. 4. A process as claimed in claim 1 wherein the alcohol used to prepare the alcoholic solution of the cyclic ketone substrate is ethanol. 5. A process as claimed in claim 1 wherein the wet fungal mycelia is obtained by growing the fungus Fusarium oxysporum f. sp. ciceri (NCIM 1282) species in a culture medium for a period of at least 2 hours at a temperature ranging between 15 to 40.degree. C. under aseptic conditions, separating the biomass, washing, and then incubating the whole reaction mixture at 15 to 40.degree. C. under shaking conditions and atmospheric pressure. 6. A process as claimed in claim 5 wherein the biomass is separated by centrifugation or filtration. 7. A process as claimed in claim 5 wherein the biomass is washed several times with sterile water. 8. A process as claimed in claim 5 wherein the whole reaction mixture is incubated while shaking at 200 rpm. 9. A process as claimed in claim 5 wherein the culture medium comprises malt extract-glucose-yeast extract -peptone. 10. A process as claimed in claim 1 wherein the concentration of the substrate per gram of the wet fungal mycelia is in the range of 1 to 50 mg. 11. A process as claimed in claim 1 wherein the concentration of the substrate per gram of the wet fungal mycelia is in the range of 3-30 mg. 12. A process as claimed in claim 1 wherein the concentration of the substrate per gram of the wet fungal mycelia is in the range of 5-10 mg. 13. A process as claimed in claim 1 wherein the reaction between substrate and wet fungal mycelia is carried out in water. 14. A process as claimed in claim 13 wherein the ratio of wet fungal mycelia to water being in the range of 1 and 100 (w/w). 15. A process as claimed in claim 1 wherein the incubation/reaction temperature is in the range of 23-33.degree. C. 16. A process as claimed in claim 15 wherein the incubation/reaction temperature is in the range of 25-29.degree. C.

Details for Patent 6,559,322

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2039-09-23